NCT07125950View on ClinicalTrials.gov

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

January 31, 2028

Conditions

Advanced Breast Cancer

Interventions

DRUG

SHR2554

SHR2554

DRUG

HRS-8080

HRS-8080

DRUG

HRS-1358

HRS-1358

Trial Locations (1)

450003

Henan Cancer Hospital, Zhengzhou

All Listed Sponsors

lead

Henan Cancer Hospital

OTHER_GOV